NCT03686683
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer treatment 3 completed NCT04586543
Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma treatment 2 recruiting NCT01368003
STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling treatment 2 withdrawn NCT00243321
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer No drug interventions treatment Not Available completed NCT04097002
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. No drug interventions treatment 1 / 2 active_not_recruiting NCT02184533
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer treatment 1 completed NCT03432897
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes treatment 2 terminated NCT01093183
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer treatment 1 / 2 terminated NCT01023061
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer treatment 2 completed NCT00109811
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer treatment 2 completed NCT01498978
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 completed NCT00459407
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate No drug interventions prevention 1 completed NCT02217709
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer treatment 2 completed NCT02278185
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer supportive_care 2 active_not_recruiting NCT01028885
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate No drug interventions treatment 1 completed NCT01882985
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients treatment 2 completed NCT01949337
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer treatment 3 active_not_recruiting NCT01468532
Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 1 / 2 completed NCT00466752
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer treatment 2 completed NCT03077659
Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer treatment 2 completed NCT01050842
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer treatment 0 completed NCT03689699
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) treatment 1 / 2 active_not_recruiting NCT00080899
Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer treatment 2 completed NCT02058706
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer treatment 2 completed NCT01408706
The Prostate Immobilization Device Study No drug interventions treatment Not Available completed NCT00450749
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer treatment 2 completed NCT01655836
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer No drug interventions treatment 1 active_not_recruiting NCT02064036
Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate treatment 1 completed NCT01433913
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery treatment 2 completed NCT00879619
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients treatment 1 / 2 terminated NCT02163317
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer No drug interventions treatment Not Available completed NCT00003517
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer treatment 2 withdrawn NCT04694924
Prospective Prostate Cancer and Patient-reported Outcomes Registry No drug interventions Not Available Not Available recruiting NCT02523924
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy diagnostic Not Available completed NCT01992016
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine diagnostic Not Available completed NCT00598858
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate treatment 2 withdrawn NCT00181558
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone treatment 2 completed NCT01117935
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer No drug interventions treatment Not Available completed NCT00430235
A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer treatment 2 completed NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer treatment 1 active_not_recruiting NCT00087139
Ixabepilone in Treating Patients With Metastatic Prostate Cancer treatment 2 completed NCT00005039
Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) treatment 2 terminated NCT02225925
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound No drug interventions treatment Not Available completed NCT01664130
High-Dose Stereotactic Radiation for Prostate Cancer No drug interventions treatment Not Available completed NCT00764166
A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel treatment 3 unknown_status NCT01703065
Cabozantinib in Men With Castration-Resistant Prostate Cancer treatment 2 terminated NCT01807065
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer treatment 2 completed NCT00608920
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping No drug interventions diagnostic Not Available completed NCT01927627
Enzalutamide in Patients With High-risk Prostate Cancer treatment 2 completed NCT03624660
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer No drug interventions treatment Not Available active_not_recruiting NCT04909294
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma No drug interventions treatment Not Available active_not_recruiting NCT01255891
Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate No drug interventions prevention 2 active_not_recruiting NCT00450229
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer treatment 1 completed NCT02296229
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer No drug interventions treatment Not Available active_not_recruiting NCT00118092
17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy treatment 2 completed NCT00331344
Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy treatment 1 / 2 completed NCT01656304
Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy treatment 2 completed NCT02237612
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer No drug interventions diagnostic Not Available completed NCT00520481
Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer treatment 2 completed NCT00040755
BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy treatment 2 completed NCT00438464
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery treatment 2 completed NCT02234921
Pilot Study of DRibble Vaccine for Prostate Cancer Patients treatment 1 completed NCT02176902
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer No drug interventions prevention Not Available active_not_recruiting NCT00058084
Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer treatment 2 completed NCT01228084
Sulforaphane in Treating Patients With Recurrent Prostate Cancer treatment 2 completed NCT01697384
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer treatment 3 completed NCT01054079
Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer treatment 2 completed NCT01126879
Genistein in Treating Patients With Prostate Cancer No drug interventions treatment 2 terminated NCT01402154
EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients No drug interventions Not Available Not Available unknown_status NCT01517451
Radiation and Androgen Ablation for Prostate Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT00337077
Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy treatment 2 completed NCT01094288
A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen treatment 1 completed NCT00016107
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer treatment 2 completed NCT01913015
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 1 terminated NCT00182052
Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer treatment 3 completed NCT00570700
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer treatment 2 completed NCT00636259
Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer Not Available Not Available no_longer_available NCT01832259
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection treatment 2 completed NCT03535675
Muscadine Plus (MPX) In Men With Prostate Cancer No drug interventions treatment 3 terminated NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment treatment 2 completed NCT01174199
Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer treatment 1 terminated NCT00096499
SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel treatment 2 completed NCT01949519
Docetaxel and Lycopene in Metastatic Prostate Cancer treatment 1 completed NCT00527124
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy treatment 2 terminated NCT03511196
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer treatment 0 active_not_recruiting NCT01394263
Study of Histrelin Subdermal Implant in Patients With Prostate Cancer treatment 3 completed NCT00915122
Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate No drug interventions treatment 1 / 2 completed NCT04909957
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT00666666
R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer treatment 2 completed NCT01795365
Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer No drug interventions treatment Not Available terminated NCT01912820
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery prevention 1 completed NCT03327662
Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer No drug interventions treatment 3 terminated NCT02840162
Pre-Prostatectomy Celecoxib or Placebo treatment 2 terminated NCT01270880
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy treatment 2 completed NCT02761889
Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer No drug interventions treatment Not Available unknown_status NCT01859689
Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer No drug interventions treatment 2 withdrawn NCT01848067
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer treatment 1 / 2 completed NCT00005067
Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer treatment 1 terminated NCT00039104
Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer treatment 2 completed NCT01682772
TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer treatment 2 unknown_status NCT01812668
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer treatment Not Available completed NCT00512668
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer treatment 1 terminated NCT02525068
A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC treatment 2 unknown_status NCT00321646
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy treatment 2 completed NCT01533246
Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate Cancer treatment 2 completed NCT00020046
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer treatment 2 completed NCT01200810
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer treatment 2 terminated NCT02203695
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy treatment 2 active_not_recruiting NCT00019695
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer treatment 2 terminated NCT00110214
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy treatment 3 completed NCT00058214
Perifosine in Treating Patients With Recurrent Prostate Cancer treatment 2 terminated NCT02048150
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer No drug interventions diagnostic 1 completed NCT01866423
Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 terminated NCT03554369
Stereotactic Body Radiation Therapy for Low and Intermediate Risk Prostate Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT02258087
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer. No drug interventions treatment 2 / 3 unknown_status NCT03518853
Short Course Radiotherapy for Localized Prostate Cancer No drug interventions treatment Not Available completed NCT01994239
Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy treatment 2 active_not_recruiting NCT02342626
Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer No drug interventions supportive_care Not Available completed NCT01952223
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse treatment 3 active_not_recruiting NCT02025361
Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy diagnostic 4 completed NCT00140478
Mifepristone (RU-486) in Androgen Independent Prostate Cancer treatment 2 completed NCT02024685
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial No drug interventions supportive_care Not Available terminated NCT02672449
Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer No drug interventions treatment Not Available recruiting NCT01913717
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion No drug interventions treatment Not Available active_not_recruiting NCT04687969
Multimodal Machine Learning Characterization of Solid Tumors No drug interventions Not Available Not Available recruiting NCT01011751
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma treatment 3 completed NCT02987829
Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients No drug interventions treatment 1 / 2 completed NCT06141993
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials No drug interventions Not Available Not Available recruiting NCT06446648
Impact of Intraoperative ICG on Functional Outc in RARP treatment 0 recruiting NCT06499870
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial treatment 2 recruiting NCT04134260
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer treatment 3 recruiting NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor treatment 2 recruiting NCT06067269
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial treatment 2 recruiting NCT01985828
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer No drug interventions treatment Not Available completed NCT05064111
Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy No drug interventions Not Available Not Available suspended NCT05496959
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study treatment 2 active_not_recruiting NCT04985565
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer No drug interventions treatment Not Available active_not_recruiting NCT05055843
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer No drug interventions screening Not Available active_not_recruiting NCT05665738
Two-fraction HDR Monotherapy for Localized Prostate Cancer No drug interventions treatment Not Available recruiting NCT05679388
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients treatment 1 terminated NCT05931419
High-Risk prostatE Cancer radiatiOn Versus surgERy No drug interventions Not Available Not Available recruiting NCT06022822
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial No drug interventions prevention 2 recruiting NCT06184464
Prostatic Size Reduction Following of Leuprorelin Acetate No drug interventions Not Available Not Available recruiting NCT06312670
Combining EPI-7386 with Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer treatment 2 recruiting NCT06330805
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer treatment 2 recruiting NCT06369610
Risk Stratified De-escalated Hormone Therapy with Radiation Therapy for the Treatment Prostate Cancer treatment 2 recruiting NCT05779943
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer diagnostic 2 active_not_recruiting NCT04543903
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer No drug interventions treatment Not Available recruiting NCT04428203
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer treatment 1 completed NCT03739684
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer diagnostic 3 completed NCT05050084
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score treatment 3 recruiting NCT01163084
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer treatment 1 / 2 terminated NCT04519879
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA No drug interventions treatment 2 recruiting NCT02721979
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance treatment 2 terminated NCT03899987
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery treatment 2 suspended NCT04037254
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer treatment 2 active_not_recruiting NCT02673151
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment diagnostic 2 / 3 completed NCT01737151
Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer No drug interventions treatment Not Available terminated NCT01709253
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma No drug interventions treatment Not Available completed NCT04146077
Active Surveillance for Low Risk Prostate Cancer No drug interventions Not Available Not Available recruiting NCT05001477
Customized TULSA-PRO Ablation Registry No drug interventions Not Available Not Available recruiting NCT03368547
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery No drug interventions diagnostic Not Available completed NCT02031328
Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT05415228
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer Not Available Not Available no_longer_available NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging treatment 3 recruiting NCT06257693
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer treatment 1 recruiting NCT04777071
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer diagnostic 2 recruiting NCT05960578
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study treatment 2 recruiting NCT05998278
Personalized Optimization of Systematic Prostate Biopsy No drug interventions diagnostic Not Available recruiting NCT06029088
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer No drug interventions Not Available Not Available completed NCT01347788
Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer treatment 1 completed NCT06347809
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine No drug interventions Not Available Not Available enrolling_by_invitation NCT04624256
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial No drug interventions treatment Not Available active_not_recruiting NCT04400656
PROState Pathway Embedded Comparative Trial No drug interventions Not Available Not Available completed NCT04391556
Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma treatment 2 unknown_status NCT05806515
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation treatment 2 recruiting NCT03999515
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer treatment 2 terminated NCT04870515
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study No drug interventions prevention Not Available recruiting NCT03285815
Prostate Cancer - Localized Adenocarcinoma Proton Therapy No drug interventions treatment Not Available recruiting NCT05744115
Ga-68-PSMA-11 in Men With Prostate Cancer No drug interventions diagnostic 3 terminated NCT00379132
131-I-TM-601 Study in Adults With Solid Tumors treatment 1 completed NCT05003752
Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer treatment 1 / 2 active_not_recruiting NCT05610852
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound No drug interventions treatment Not Available recruiting NCT04377152
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer Not Available Not Available approved_for_marketing NCT05600400
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer No drug interventions treatment Not Available recruiting NCT03581500
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer No drug interventions diagnostic 2 active_not_recruiting NCT06200259
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement No drug interventions treatment Not Available recruiting NCT02268175
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate treatment 2 completed NCT03933670
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance No drug interventions diagnostic 2 recruiting NCT03698370
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer No drug interventions diagnostic 2 completed NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy No drug interventions diagnostic 2 recruiting NCT06235099
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer diagnostic 3 recruiting NCT04638049
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) No drug interventions basic_science Not Available completed NCT02564549
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca No drug interventions diagnostic Not Available terminated NCT01120236
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer treatment 2 completed NCT01411319
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer No drug interventions treatment Not Available completed NCT03649841
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer treatment 2 terminated NCT05852041
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance No drug interventions diagnostic 0 recruiting NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 No drug interventions treatment 2 active_not_recruiting NCT04331717
Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer supportive_care 2 withdrawn NCT05751434
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer No drug interventions treatment 2 recruiting NCT05919524
SBRT With Focal Dose Escalation on DIL in Localized Prostate Cancer No drug interventions treatment Not Available recruiting NCT03412396
Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy treatment 2 active_not_recruiting NCT03361735
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer treatment 2 active_not_recruiting NCT03255135
Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. No drug interventions treatment Not Available unknown_status NCT02499835
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer treatment 1 / 2 completed NCT04286386
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam No drug interventions Not Available Not Available active_not_recruiting NCT05832086
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes No drug interventions treatment 2 recruiting NCT02339948
Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma No drug interventions treatment Not Available completed NCT05197257
68Ga-PSMA-11 PET in Patients With Prostate Cancer No drug interventions diagnostic 3 completed NCT00170157
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer treatment 2 completed NCT01661166
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy treatment 4 completed NCT01898065
Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer diagnostic 2 completed NCT02228265
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide Not Available Not Available completed NCT01838265
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management No drug interventions Not Available Not Available withdrawn NCT04175431
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study treatment 2 recruiting NCT03570827
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy No drug interventions treatment 2 active_not_recruiting NCT03805594
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer treatment 1 active_not_recruiting NCT04825691
ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological Features No drug interventions Not Available Not Available unknown_status NCT04085991
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer No drug interventions treatment 2 terminated NCT02168062
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer supportive_care 2 terminated NCT01352429
Mild Hypofractionation With Proton Therapy or Intensity Modulated Radiation Therapy (IMRT) for Intermediate-Risk Prostate Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04951492
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma treatment 2 terminated NCT03501940
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer No drug interventions Not Available Not Available no_longer_available NCT03796767
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer No drug interventions treatment 2 active_not_recruiting NCT02285101
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors treatment 1 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT00589472
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer treatment 2 completed NCT01505868
Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer treatment 1 / 2 completed NCT00937768
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy treatment 2 terminated NCT01148069
Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers No drug interventions treatment 2 completed NCT01530269
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma No drug interventions diagnostic 2 completed NCT02254746
A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer No drug interventions treatment Not Available active_not_recruiting NCT03821246
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy treatment 2 recruiting NCT06299046
Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study No drug interventions Not Available Not Available completed NCT03553212
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy No drug interventions treatment Not Available terminated NCT03516812
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer treatment 2 completed NCT02175212
Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer No drug interventions treatment 3 completed NCT03504995
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. No drug interventions treatment Not Available completed NCT01519414
Tivantinib in Treating Patients With Metastatic Prostate Cancer treatment 2 completed NCT05022914
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE No drug interventions Not Available Not Available recruiting NCT04946214
A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients No drug interventions supportive_care Not Available completed NCT04486755
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) No drug interventions treatment 1 recruiting NCT04300855
Clinical Trial of Green Tea Catechins in Men on Active Surveillance other 2 recruiting NCT01856855
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) No drug interventions treatment Not Available completed NCT03279250
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer treatment 2 completed NCT03204123
PSMA PET Imaging of Recurrent Prostate Cancer No drug interventions diagnostic 2 active_not_recruiting NCT03780023
CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients No drug interventions Not Available Not Available completed NCT01145508
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 terminated NCT05109208
The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction No drug interventions health_services_research Not Available recruiting NCT06387238
Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT03718338
Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma No drug interventions Not Available Not Available terminated NCT04336943
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load treatment 2 active_not_recruiting NCT03494803
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC No drug interventions Not Available Not Available withdrawn NCT01219790
ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma treatment 1 completed NCT04192890
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer No drug interventions treatment Not Available unknown_status NCT03830164
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer treatment 2 completed NCT05683964
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression diagnostic 0 recruiting NCT04288687
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects treatment 2 active_not_recruiting NCT03274687
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer No drug interventions treatment 3 active_not_recruiting NCT06235151
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer diagnostic 3 recruiting NCT03431753
Early and Accurate Detection of Prostate Cancer in General Practice No drug interventions diagnostic Not Available unknown_status NCT02346253
High-Dose Brachytherapy in Treating Patients With Prostate Cancer treatment Not Available active_not_recruiting NCT05027477
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer No drug interventions treatment Not Available recruiting NCT03246347
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer treatment 2 active_not_recruiting NCT04049747
Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer No drug interventions treatment Not Available recruiting NCT05647447
Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate treatment 0 withdrawn NCT01411345
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial No drug interventions treatment Not Available active_not_recruiting NCT04704505
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) treatment 2 recruiting NCT06292897
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression No drug interventions Not Available Not Available recruiting NCT00181597
Trilostane for Androgen-Independent Prostate Cancer treatment 2 completed NCT02981797
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 No drug interventions Not Available Not Available completed NCT02853097
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients No drug interventions Not Available Not Available terminated NCT04284761
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer treatment 1 completed NCT03561961
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) No drug interventions treatment Not Available recruiting NCT03860961
Survivorship Care Planning for Prostate Cancer Survivors No drug interventions health_services_research Not Available active_not_recruiting NCT04221828
Trial of NanoPac Focal Therapy for Prostate Cancer treatment 2 terminated NCT01325311
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer treatment 2 completed NCT02491411
Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel treatment Not Available terminated NCT03996993
Defining Recurrent Disease With Axumin™ Not Available Not Available unknown_status NCT04031378
Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer No drug interventions treatment 2 unknown_status NCT02600156
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors No drug interventions treatment Not Available recruiting NCT00773656
Patients Overexposed for a Prostate Adenocarcinoma No drug interventions Not Available Not Available completed NCT04050215
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer diagnostic 2 completed NCT05599737
Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA) No drug interventions treatment Not Available unknown_status NCT05902637
The Efficacy Of Mapping For Cognitive Prostate Biopsy No drug interventions diagnostic Not Available recruiting NCT00887432
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation No drug interventions treatment Not Available completed NCT01411332
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial No drug interventions treatment Not Available completed NCT04530552
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland prevention 2 recruiting NCT05053152
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer treatment 2 recruiting NCT04465500
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer No drug interventions treatment 2 recruiting NCT03762759
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes treatment 2 active_not_recruiting NCT04978675
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer diagnostic 1 completed NCT04126070
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors treatment 2 active_not_recruiting NCT03034070
Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. No drug interventions diagnostic Not Available completed NCT04384770
CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study No drug interventions Not Available Not Available active_not_recruiting NCT05607342
Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate treatment 0 terminated NCT04945642
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma No drug interventions treatment Not Available recruiting NCT01253642
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel treatment 2 terminated NCT04943536
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer treatment 1 recruiting NCT06238713
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) No drug interventions treatment Not Available recruiting NCT06105918
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer treatment 1 recruiting NCT02624518
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer diagnostic 2 / 3 completed NCT02454517
Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer No drug interventions supportive_care Not Available terminated NCT04513717
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial treatment 3 recruiting NCT04446117
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC treatment 3 active_not_recruiting NCT02206334
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer No drug interventions treatment 1 completed NCT04743934
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer treatment 2 active_not_recruiting NCT05224024
Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy No drug interventions other Not Available unknown_status NCT00183924
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. treatment 2 completed NCT04399824
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer No drug interventions treatment Not Available withdrawn NCT05803096
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain supportive_care 4 completed NCT05709496
Dose De-escalation in Prostate Radiotherapy Using the MRL No drug interventions treatment Not Available recruiting NCT05589558
Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection No drug interventions diagnostic Not Available completed NCT03474835
Ischemic Heart Disease in Male With Prostate Adenocarcinoma No drug interventions diagnostic Not Available unknown_status NCT05676463
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer No drug interventions treatment 2 suspended NCT03963739
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03880422
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT04252625
Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis No drug interventions treatment 2 terminated NCT03829930
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer treatment 1 terminated NCT03404648
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI diagnostic 3 completed NCT06044857
PSMA PET Response Guided SabR in High Risk Pca No drug interventions treatment 1 recruiting NCT04976257
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion treatment 0 completed NCT06518226
Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer No drug interventions treatment Not Available recruiting NCT02603965
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery No drug interventions diagnostic 1 completed NCT01786265
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer treatment 2 active_not_recruiting NCT03396874
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence diagnostic 2 completed NCT01787331
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer treatment 2 completed NCT03982173
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors treatment 2 withdrawn NCT04019327
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer treatment 1 / 2 active_not_recruiting NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT03177460
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer treatment 1 completed NCT04020094
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer treatment 2 withdrawn NCT03822494
CyberKnife Dose Escalation Prostate Cancer Trial No drug interventions treatment Not Available recruiting NCT00536991
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer treatment 1 / 2 terminated NCT02940262
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy No drug interventions diagnostic 3 completed NCT04983862
Fluorescent Imaging of Nerves With Illuminare-1 During Surgery No drug interventions treatment 1 recruiting NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy No drug interventions screening Not Available recruiting NCT05919329
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy diagnostic 4 recruiting NCT05276492
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. treatment 1 active_not_recruiting NCT03821792
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer treatment 2 active_not_recruiting NCT05726292
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer treatment 2 recruiting NCT03496844
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma No drug interventions diagnostic Not Available completed NCT01953640
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy No drug interventions Not Available Not Available active_not_recruiting NCT04190446
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment No drug interventions treatment 2 active_not_recruiting NCT01731912
Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer treatment Not Available completed NCT03451812
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT03204812
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer treatment 2 completed NCT01478412
An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT06392295
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer No drug interventions treatment 2 recruiting NCT05735223
A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence No drug interventions prevention Not Available completed NCT01026623
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer treatment 1 / 2 completed NCT04915508
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy No drug interventions treatment 2 recruiting NCT04030338
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03654638
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer No drug interventions other 2 active_not_recruiting NCT03503643
Hemi-Gland Cryoablation for Prostate Cancer at UCLA No drug interventions Not Available Not Available enrolling_by_invitation NCT04144010
Gallium-68 PSMA-11 PET/CT for the Diagnosis of Biochemically Recurrent Prostate Cancer diagnostic 2 recruiting